More patients with pediatric-onset multiple sclerosis (POMS) are free of new or newly enlarging (N or NE) T2 hyperintense lesions with dimethyl fumarate (DMF) versus interferon […]
Levels of key immune-signaling molecules in the vagina “undergo clear and consistent” fluctuations during the menstrual cycle, a University of Washington Medicine-led team reports in a […]
Systemic sclerosis—or scleroderma that affects the skin and internal organs—is one of the rarest autoimmune diseases, affecting roughly 100,000 people (primarily women) in the United States. […]
Patients from historically medically underserved groups, including patients of color and those who are Spanish-speaking, have less cancer family history information available to them than do […]